Volume 44, Issue 5 pp. 918-927
ORIGINAL ARTICLE

Revealing molecular architecture of FLT3 internal tandem duplication: Development and clinical validation of a web-based application to generate accurate nomenclature

Yi Ding

Yi Ding

Department of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA

Search for more papers by this author
Geoffrey Hughes Smith

Geoffrey Hughes Smith

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

Search for more papers by this author
Kristin Deeb

Kristin Deeb

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

Search for more papers by this author
Thomas Schneider

Thomas Schneider

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

Search for more papers by this author
Andrew Campbell

Andrew Campbell

Department of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA

Search for more papers by this author
Linsheng Zhang

Corresponding Author

Linsheng Zhang

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

Correspondence

Linsheng Zhang, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 531 Asbury Circle, Suite N252A, Atlanta, GA 30322, USA.

Email: [email protected]

Search for more papers by this author
First published: 06 July 2022

Abstract

Introduction

FLT3 internal tandem duplicate (ITD) is associated with unfavorable prognosis of acute myeloid leukemia; targeted therapy improves clinical outcome. We propose that FLT3-ITD detected by next generation sequencing (NGS) should be reported with the same nomenclature pattern as single nucleotide variants so that the mutation can be better interpreted clinically.

Methods

A Python-based web application was developed to generate FLT3-ITD nomenclature as recommended by the Human Genome Variation Society (HGVS). Assembled FLT3-ITD sequences from 84 patients and 11 artificially created ITD sequences were used for the validation of this web-based application. Each sequence was inspected manually to confirm that the nomenclature was accurate.

Results

Accurate nomenclatures were generated for 113 of 114 sequencing results and 7 artificial sequences. One assembled sequence and four artificial sequences were not named accurately; warning statements were automatically generated to alert further inspection. Of the 105 unique FLT3-ITDs, the ITD lengths range from 18 to 300 bp. Depending whether the ITD involves intron or extends into exon 15, three patterns were recognized. Only 44 (42%) ITDs were pure duplications, and three types of variants were identified at the 5′ of ITD. When ITD involves intronic sequence, the protein may comprise inserted amino acids encoded by the intron, due to disrupted RNA splicing.

Conclusion

The web application generates accurate FLT3-ITD nomenclature from NGS results except in rare situations. The HGVS nomenclatures provide information on the molecular architecture of FLT3-ITDs and reveal details of complex insertions with partial duplications.

CONFLICT OF INTEREST

The authors declare no conflict of interest related to the subject matter or material discussed in this article.

DATA AVAILABILITY STATEMENT

Data available on request due to privacy/ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.